Diagnostic options · UAE

Pharmacogenetics tests in Dubai & UAE

Compare available Pharmacogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

700.00–6,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Pharmacogenetics test prices

Showing 1–11 of 11 matching tests.

Pharmacogenetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-668 Clopidogrel CYP2C19 Genotype Test This test evaluates genetic variations in the CYP2C19 gene that influence the metabolism and effectiveness of the antiplatelet drug clopidogrel.	Peripheral Whole Blood (EDTA Lavender Top Tube)	7–10 business days	6,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP2C19 gene variants (2, 3, *17 alleles)", "Metabolizer status (Normal, Intermediate, Poor)"] Parameters [] Preparation ["No fasting required", "No special preparation required"] Indications ["Patients prescribed clopidogrel", "Patients post-coronary stent placement", "Patients post-heart attack", "Personalized antiplatelet therapy"] Measurement technique Confirm with laboratory Codes LOINC: 47344-8 ICD-10: Z13.89 Clinical summary This test evaluates genetic variations in the CYP2C19 gene that influence the metabolism and effectiveness of the antiplatelet drug clopidogrel.
TEST-6196 CYP2C19 Genotyping (Drug Metabolism) Genetic Test This test evaluates genetic variants in the CYP2C19 gene to predict drug metabolism efficiency.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP2C19 gene variants (2, 3, *17, and others)", "Metabolizer phenotype (poor, intermediate, extensive, ultrarapid)"] Parameters [] Preparation ["Fasting is not required.", "Inform the phlebotomist of all current medications and supplements."] Indications ["Patients prescribed drugs metabolized by CYP2C19 (e.g., clopidogrel, PPIs, SSRIs)", "Patients experiencing adverse drug reactions or therapeutic failure with CYP2C19 substrates"] Measurement technique Confirm with laboratory Codes LOINC: 81803-3 ICD-10: Z13.81, Z84.8 Clinical summary This test evaluates genetic variants in the CYP2C19 gene to predict drug metabolism efficiency.
TEST-1678 Cytochrome P450 2C19 Genotyping (CYP2C19) Clopidogrel Resistance (2,3,4,10) Test This test evaluates the genetic variants in the CYP2C19 gene that influence the metabolism of the antiplatelet drug clopidogrel.	Peripheral Whole Blood	7 Working Days (Expedited Available)	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP2C19 gene variants (2, 3, 4, 10)", "Clopidogrel metabolism phenotype (Poor, Intermediate, Extensive)"] Parameters [] Preparation ["No specific fasting required", "No need to stop current medications unless advised by your physician"] Indications ["Patients prescribed clopidogrel", "Patients with cardiovascular risk factors", "Patients undergoing percutaneous coronary intervention (PCI)"] Measurement technique Confirm with laboratory Codes LOINC: 65737-8 ICD-10: Z13.81 Clinical summary This test evaluates the genetic variants in the CYP2C19 gene that influence the metabolism of the antiplatelet drug clopidogrel.
TEST-6342 DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency Genetic Test This genetic test evaluates the DPYD gene for variants associated with dihydropyrimidine dehydrogenase deficiency, predicting risk of severe toxicity to fluoropyrimidine chemothera...	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DPYD gene variants", "Enzyme deficiency risk"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9% (detects rare/novel variants)"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS) with full gene coverage and CNV analysis"}] Preparation ["Mandatory genetic counselling session", "Provide complete clinical history"] Indications ["Patients scheduled to receive 5‑fluorouracil or capecitabine", "Patients with family history of severe drug reactions"] Measurement technique Confirm with laboratory Codes LOINC: 94213-5 ICD-10: Z13.89 Clinical summary This genetic test evaluates the DPYD gene for variants associated with dihydropyrimidine dehydrogenase deficiency, predicting risk of severe toxicity to fluoropyrimidine chemotherapy.
TEST-1505 HLA-B1502 Genotyping (Carbamazepine) Test This diagnostic test evaluates the presence or absence of the HLA-B1502 allele, a genetic variant linked to severe adverse reactions to carbamazepine.	Peripheral Whole Blood (EDTA Tube)	10 Working Days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of HLA-B1502 allele", "Genetic predisposition to carbamazepine-induced SCARs"] Parameters [{"name": "HLA-B1502 Allele", "reference_range": "Negative / Positive"}] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Pre-therapy screening for carbamazepine", "Patients of Asian descent initiating carbamazepine", "Risk assessment for SJS/TEN"] Measurement technique Confirm with laboratory Codes LOINC: 79529-5 ICD-10: Z13.89 Clinical summary This diagnostic test evaluates the presence or absence of the HLA-B*1502 allele, a genetic variant linked to severe adverse reactions to carbamazepine.
TEST-1498 HLA-B57:01 Genotyping (Abacavir Hypersensitivity) Test This test detects the presence or absence of the HLA-B57:01 allele in a patient's DNA.	Peripheral Whole Blood	7 Working Days	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of HLA-B57:01 allele"] Parameters [] Preparation ["No special preparation required", "Inform your physician of any current medications", "Do not discontinue prescribed therapy without medical consultation"] Indications ["Mandatory screening before initiating abacavir therapy in the UAE", "Patients prescribed abacavir"] Measurement technique Confirm with laboratory Codes LOINC: 90839-9 ICD-10: Z13.89 Clinical summary This test detects the presence or absence of the HLA-B57:01 allele in a patient's DNA.
TEST-1470 Irinotecan Toxicity Assessment (UGT1A1 Genotyping)/Gilbert Syndrome Test This test evaluates genetic variants in the UGT1A1 gene associated with irinotecan toxicity and Gilbert syndrome.	Peripheral Blood (EDTA tube)	7–8 Days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["UGT1A1 gene variants (28, 6, *60)", "Genetic predisposition to irinotecan toxicity", "Genetic confirmation of Gilbert syndrome"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Predicting severe adverse reactions to irinotecan chemotherapy", "Diagnosing Gilbert syndrome", "Personalizing irinotecan dosage"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z13.89, E80.4 Clinical summary This test evaluates genetic variants in the UGT1A1 gene associated with irinotecan toxicity and Gilbert syndrome.
TEST-1283 NUDT15 Gene Mutation Analysis Test This test identifies genetic variants in the NUDT15 gene that affect thiopurine metabolism.	Peripheral Blood	12 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NUDT15 gene variants (e.g., R139C)", "Thiopurine metabolism risk"] Parameters [] Preparation [] Indications ["Patients starting azathioprine or 6-mercaptopurine", "Autoimmune conditions", "Oncologic conditions", "Gynecologic conditions", "Asian or Middle Eastern populations"] Measurement technique Confirm with laboratory Codes LOINC: 94803-7 ICD-10: Z13.89 Clinical summary This test identifies genetic variants in the NUDT15 gene that affect thiopurine metabolism.
TEST-1080 Thiopurine Methyltransferase (TPMT Test This test evaluates genetic variants in the TPMT gene that affect the activity of the Thiopurine Methyltransferase enzyme, predicting drug metabolism capacity.	Peripheral whole blood (EDTA or citrate)	5–7 business days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TPMT gene variant alleles (2, 3A, 3B, 3C)", "Predicted thiopurine drug metabolism capacity"] Parameters [] Preparation ["No fasting or special preparation required.", "Provide valid Emirates ID and prescription."] Indications ["Prior to initiating thiopurine therapy (azathioprine, 6-mercaptopurine, thioguanine)", "Patients with unexplained severe myelosuppression while on thiopurines"] Measurement technique Confirm with laboratory Codes LOINC: 90330-2 ICD-10: Z13.5 Clinical summary This test evaluates genetic variants in the TPMT gene that affect the activity of the Thiopurine Methyltransferase enzyme, predicting drug metabolism capacity.
TEST-5843 TPMT Genotyping (NGS) for Thiopurine Methyltransferase Deficiency Test This test identifies genetic variations in the TPMT gene that affect the metabolism of thiopurine drugs, guiding safe dosing.	Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TPMT gene variants", "TPMT enzyme activity phenotype"] Parameters [] Preparation [] Indications ["Patients requiring thiopurine medications (azathioprine, 6-mercaptopurine, thioguanine)", "Organ transplantation", "Inflammatory bowel disease", "Autoimmune hepatitis", "Rheumatologic conditions", "Childhood acute lymphoblastic leukemia"] Measurement technique Confirm with laboratory Codes LOINC: 92806-3 ICD-10: Z13.89 Clinical summary This test identifies genetic variations in the TPMT gene that affect the metabolism of thiopurine drugs, guiding safe dosing.
TEST-1060 Warfarin Therapeutic Response Predictive Assay (VKORC1 & CYP2C9) Test This test evaluates genetic variations in the VKORC1 and CYP2C9 genes that influence warfarin metabolism and sensitivity.	Peripheral Whole Blood (EDTA)	3–4 Working Days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VKORC1 gene polymorphisms", "CYP2C9 gene polymorphisms", "Warfarin metabolism phenotype"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of anticoagulant medications"] Indications ["Patients starting warfarin therapy", "Patients experiencing difficulty achieving stable INR on warfarin", "Patients with suspected warfarin sensitivity or resistance"] Measurement technique Confirm with laboratory Codes LOINC: 93025-6 ICD-10: Z13.89 Clinical summary This test evaluates genetic variations in the VKORC1 and CYP2C9 genes that influence warfarin metabolism and sensitivity.

Category overview

Pharmacogenetics: overview

Managing chronic illness often involves frustrating medication trials, but seeing how your unique DNA interacts with drugs provides the ultimate foundation for proactive, customized care. Housed in our Molecular Diagnostics suite, our Pharmacogenetics testing leverages high-throughput genomic sequencing to analyze exactly how your body metabolizes specific medications. Instead of acting as a definitive standalone diagnosis, this expansive pharmacogenetics data empowers your physician with the critical molecular clarity required to prevent adverse reactions and provide highly personalized medical guidance. Recognized among the premier diagnostic labs in Dubai and the UAE, DNA Labs UAE ensures rigorous patient privacy and exceptionally swift, highly accurate results. Optimize your medication strategy today: discover our pharmacogenetics testing in the UAE below to book your test, arrange a seamless home collection, or speak with our medical experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.